Спайдер повышается перед открытием торгов на NYSE.  

• Европейские индексы на положительной территории.

SPY (внутридневной график)  рост   на   премаркете. Сопротивление: 158.50  Поддержка: 157.50
 
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: MITL +7.4%, LEN +5.7% .
 
M&A related: TSLA +1.4% (Bloomberg discusses M&A potential of TSLA; says valuation high, but payback of govt loan removes obstacle)
 
A few financial related names showing strength: HBC +2.6% (considering sale of Es Salaam bank stake, according to reports),  GS +1.1%, DB +1%, ING +1%.
 
Select oil/gas stocks trading higher:

( Читать дальше )

Спайдер понижается перед открытием торгов на NYSE.  

• Европейские индексы на отрицательной территории.

SPY (внутридневной график)  снижение   на   премаркете. Сопротивление: 158.00  Поддержка: 157.00
 
Премаркет NYSE/NASDAQ:
Gapping up:
M&A related: VHS +65.7% and THC +7.4% (Vanguard Health Systems to be acquired by Tenet Healthcare for $21 per share in cash), KEYN +47.2% (Keynote Systems to be acquired by Thoma Bravo for $20.00 per share).


( Читать дальше )

Спайдер понижается перед открытием торгов на NYSE.  

• Европейские индексы на отрицательной территории.

SPY (внутридневной график)  снижение   на   премаркете. Сопротивление: 160.00  Поддержка: 159.00
 
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: KMX +4.8%, TIBX +1.4%.
 
M&A related: SPRD +22.3% (announces receipt of acquisition proposal for $28.50 in cash per ADS), THRX +8.4% (Early strength being attributed to article suggesting GSK is interested in acquiring the co).

( Читать дальше )

Спайдер понижается 165.00 перед открытием торгов на NYSE.  

• Европейские индексы на отрицательной территории.

SPY (внутридневной график)  снижение   на   премаркете. Сопротивление: 162.50  Поддержка: 162.00
 
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: FNSR +9.5%, RHT +3.4%.
 
A few FNSR peers are ticking higher: OCLR +3.3%, JDSU +2.6%, CIEN +0.9%.
 
Other news: SLTM +12.1% (receives new FDA 510(k) clearance for treatment of skin pigmentation), DRRX +10.8% (thinly traded, announces FDA acceptance of NDA Submission for POSIDUR), CLSN +9.8% (ThermoDox HEAT Study Findings Reviewed; emerging post-hoc findings suggest that the heating cycles can be optimized to markedly improve radiofrequency ablation when used with ThermoDox), CLNT +6.4% (ticking higher, receives $2.0 mln in new orders for airflow-dyeing machines), NTWK +5.3% (awarded agreement valued in excess of $10 million with major global auto finance captive company), GME +4.9% ( following reversal in used games policy for Xbox One), ZN +4.9% (ticking higher, to conduct in-well testing operations at its Elijah #3 well), CYTK +4.4% (continued strength), ZLCS +3.6% (publishes preclinical data in Science Translational Medicine showing the beneficial effects of applying the Zalicus combination high-throughput screening technology for the potential treatment of ebolavirus infections), RYAAY +3% (reports that indicate the co is planning buybacks and/or special dividend), WAGE +2.3% (will be added to S&P 600), SSYS +2.2% (to acquire MakerBot for initial value of ~$403 mln in all stock transaction), CAMP +1.9% (will replace Palomar Medical Technologies S&P600), SD +1% (appoints CFO Bennet to CEO (former CEO Ward leaving the co), AEC +0.8% (will be added to S&P 600).


( Читать дальше )

Спайдер торгуется немного ниже 165.00 перед открытием торгов на NYSE.  

• Европейские индексы на положительной территории.

SPY (внутридневной график)  рост   на   премаркете. Сопротивление: 165.00  Поддержка: 164.60
 
ПремаркетNYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: KFY +4.9%.
 
M&A related: ELN +2.2% (Royalty Pharma announces withdrawal of judicial review and lapse of offer, Elan advises shareholders to withdraw any acceptances of the Royalty Pharma offer and not to tender any further acceptances into this lapsed offer).
 
Select financial related names showing strength: RBS +2.6%, NMR +2.6%, BCS +2.4%, HBC +1.7% (upgraded to Buy from Neutral at Citigroup), DB +1.4%, ING +1.1%, .
 
A few telecom names are trading higher:

( Читать дальше )

Спайдер торгуется у отметки 164.50 перед открытием торгов на NYSE.  

• Европейские индексы на положительной территории.

SPY (внутридневной график)  рост   на   премаркете. Сопротивление: 164.50  Поддержка: 164.00
 
ПремаркетNYSE/NASDAQ:
Gapping up:
M&A related: SFD +1.4% (Starboard confirms it sent letter to Board of Smithfield Foods; expresses views on company's valuation and intends to explore whether greater value is possible).

( Читать дальше )

Спайдер торгуется ниже вчерашнего закрытия перед открытием торгов на NYSE.  

• Европейские индексы на отрицательной территории.

SPY (внутридневной график)  рост   на   премаркете. Сопротивление: 161.50  Поддержка: 160.50
 
ПремаркетNYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: SPRD +24%, PVH +7.5%, FIVE +4%, MW +4%.
 
M&A news: BLC +33% (acquired by Gannett (GCI +22.5%) for $13.75/share), LFG +2.6% (in sympathy to BLC), SBGI +1.7% (in sympathy to BLC), MEG +1% (in sympathy to BLC).
 
Select metals/mining stocks trading higher: DRD +5%, RIO +2.2%, MTL +2.0%, MT +1.3%, BHP +0.9%.
 
Other news: SWY +22.2% (announced definitive agreement to sell its Canadian Operations to Sobeys for C$5.8 bln), MY +10.7% (signs strategic cooperation agreement with China National Nuclear), NRF +4.6% (announced private offering of $300 mln exchangeable senior notes due 2033), LEI +4% (announces fiscal year 2013 estimated proved and probable reserves), RSOL +3.4% (appointed David Belluck as Chairman), HMA +2.5% (engaged firms in connection with accumulation of shares by Glenview Capital Management), IVAC +2.3% (received $27 mln production contract from U.S. Army), ATRS +2% (Methotrexate for rheumatoid arthritis demonstrated significantly greater bioavailability over current standard of care), MLNX +1.9% (continued strength from yesterday).


( Читать дальше )

Спайдер повышается перед открытием торгов на NYSE.  

• Европейские индексы на положительной территории.

SPY (внутридневной график)  рост   на   премаркете. Сопротивление: 164.50  Поддержка: 164.00
 
ПремаркетNYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: ULTA +9.6%, WPPGY +2.1%, OXM +1.6%.
 
M&A news: CTB +40.5% (acquired for $35/share in cash by Indian tire company Apollo Tyres), HMA +9.8% (Glenview Capital disclosed 14.56% active stake in amended 13D filing, may engage with potential strategic partners, also upgraded at Deutsche Bank and CRT Capital), GT +6.8% (trading higher in sympathy with CTB).
 
Select financial related names showing strength: BBVA +2.8%, RBS +2%, C +1.1%, HBC +1.1%, LYG +1%, JPM +0.9%.
 


( Читать дальше )

Спайдер понижается перед открытием торгов на NYSE.  

• Европейские индексы на отрицательной территории.

SPY (внутридневной график)  снижение   на   премаркете. Сопротивление: 163.50  Поддержка: 163.00
 
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: SURG +16.1%, DMND +2.6%, GIS +0.8%.
 
M&A news: DOLE +21.6% (Dole Food announces receipt of proposal by David H. Murdock to acquire all outstanding common shares of Dole Food not already owned by Mr. Murdock or his family for $12.00 per share in cash), S +3.1% (Sprint Nextel and SoftBank amend merger agreement; increases offer by $1.48 per share,to $5.50 per share).


( Читать дальше )

Спайдер почти не изменяется перед открытием торгов на NYSE.  

• Европейские индексы изменяются разнонаправленно.

SPY (внутридневной график)  боковое движение   на   премаркете. Сопротивление: 165.00  Поддержка: 164.50
 
ПремаркетNYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance/comps: TPLM +3.1%, MCD +2.3%.
 
Select financial related names showing strength: DB +2%, RBS +1%, BAC +0.9%.
 
A few Japan related names showing strength: TM +3.4%, MTU +2.8%, SNE +2.2%, HMC +1%.
 
Other news: APRI +13.3% (receives European approval for Vitaros for the treatment of erectile dysfunction), CSIQ +6.8% (signs CAD310 mln EPC agreement for the construction of a 130 MW DC solar power plant in Ontario), TRQ +4.1% (still checking), BLRX +3% (enters into collaboration to develop and commercialize Hepatitis C Drug with CTTQ, a Chinese Pharma Company for Liver Disease Therapeutics), MTG +2.9% (releases May 2013 operating statistics; reports primary new insurance written of $2.8 bln ($2.4 bln in April); reports Ending Primary Delinquent Inventory of 119.1K (126.6K in April), FL +2.5% (positive mention in Barrons), GILD +2.3% ( announces U.S. FDA Priority Review designation for sofosbuvir for the treatment of hepatitis C ), SAP +1.5% (may be attributed to exec comments related to potential expansion via acquisitions), GMCR +1.3% (still checking), RCL +1.1% (still checking), BBRY +1% (still checking), AAPL +0.7% (Apple is expected to introduce new iOS software and a music service at WWDC today, according to reports).


( Читать дальше )